Key Peer-Reviewed Publications
VIEW Lukes A, Green MA. 3-Year Results of the SONATA Pivotal Trial of Transcervical Fibroid Ablation (TFA) for Symptomatic Uterine Myomata. J Gynecol Surg. 2020; doi: org/10.1089/gyn.2020.0021
VIEW Miller CE, Osman KM. Transcervical Radiofrequency Ablation of Symptomatic Uterine Fibroids: 2-Year Results. J Gynecol Surg. 2019; doi: 10.1089/gyn.2019.0012
VIEW Bradley LD, Pasic RP, Miller LE. Clinical Performance of Radiofrequency Ablation for Treatment of Uterine Fibroids: Systematic Review and Meta-Analysis of Prospective Studies. J Laparoendosc Adv Surg Tech. 2019; https://doi.org/10.1089/lap.2019.0550.
VIEW Chudnoff S, Guido R, Roy K, Levine D, Mihalov L, Garza-Leal JG. Ultrasound-Guided Transcervical Ablation of Uterine Leiomyomas. Obstet Gynecol. 2019 Jan; 133(1): 13-22
VIEW Garza-Leal JG. Long-Term Clinical Outcomes of Transcervical Radiofrequency Ablation of Uterine Fibroids: The VITALITY Study. Journal of Gynecologic Surgery. 2019; 35:19-23.
VIEW Brölmann H, Bongers M, Garza-Leal J, Gupta J, et al. The FAST-EU trial: 12-month clinical outcomes of women after intrauterine sonography-guided transcervical radiofrequency ablation of uterine fibroids. Gynecol Surg. 2016; 13: 27-35.
VIEW Taheri M, Galo L, Potts C, Sakhel K, Quinn SD. Nonresective treatments for uterine fibroids: a systematic review of uterine and fibroid volume reductions. International Journal of Hyperthermia. 2019; 1-7.
VIEW Huirne J, Brooks E. Improvement in health utility after transcervical radiofrequency ablation of uterine fibroids with the Sonata System: Health utility after radiofrequency ablation. Eur J Obstet Gynecol Reprod Biol. 2018; 224: 175-180.
VIEW Toub, DB. A New Paradigm for Uterine Fibroid Treatment: Transcervical, Intrauterine Sonography-Guided Radiofrequency Ablation of Uterine Fibroids with the Sonata System. Curr Obstet Gynecol Rep. 2017;6(1):67-73.
VIEW Bongers M, Brölmann H, Gupta J, Garza-Leal JG, Toub D. Transcervical, intrauterine ultrasound-guided radiofrequency ablation of uterine fibroids with the VizAblate® System: three- and six-month endpoint results from the FAST-EU study. Gynecol Surg. 2015;12(1):61-70.
VIEW Jones, S., O’Donovan, P, Toub, D. Radiofrequency ablation for treatment of symptomatic uterine fibroids. Obstet Gynecol Int.2012; 2012:194839.
VIEW Garza-Leal, JG, Toub, D, León, IH, et al. Transcervical, intrauterine ultrasound-guided radiofrequency ablation of uterine fibroids with the VizAblate System: safety, tolerability, and ablation results in a closed abdomen setting. Gynecol Surg (2011) 8: 327.